A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
141 Focus on triggering factors in sensitive skin: two biomarkers in a new heat-cold stress in vivo model
2022
Journal of Investigative Dermatology
Preserved Fulltext
Real-world studies on the use of biologics in psoriasis (Pso) are increasing, but still scarce. Next, interleukin-17 inhibitors (IL-17i) trough concentrations (C t ) seem promising for clinical decision making, however its value in daily practice has yet to be proven. Objectives were to report on IL-17i effectiveness, treatment modifications, and C t use in our clinic. Data was collected from IL-17i treated Pso patients followed up in the PsoPlus clinic at the
doi:10.1016/j.jid.2022.09.151
fatcat:rq35h3abhbdchjb6slptrhxmge